Post by Antoine DE LACOMBE

Advancing Parkinson’s Drug Discovery at Ksilink 📢Thrilled to announce a major milestone! Based on our unique phenotypic screening capabilities, we have discovered a novel mechanism to potentially treat a-synucleinopathies in Parkinson’s disease. We have unravelled the molecular target and are now in early lead optimization. 👏 Huge congratulations to the Ksilink team and thanks to our partners for their support. An impressive achievement! 🚀We are now bringing together a group of funding partners to drive this program toward IND. Interested in a fresh, first‑in‑class approach to PD? Let’s connect. Mona Boyé Helmut Haning Johannes Wilbertz Karen Schmitt, PhD Kayhan Alvandipour @amelie weiss Amandine ZIMMERMANN David Hoffmann François Kien Arnaud Ogier Zahra Hanifehlou Rejko Krüger Clemens Ostrowicz Alain Beretz @andré syrota Ulf Nehrbass Michael Platten Jacques Volckmann Franck lethimonnier Michel de Mathelin Caroline Dreyer Bert M. Klebl Andreas Meyer-Lindenberg Wolfram Zimmermann Braun Serge @Oliver Brüstle Prof. Dr. Oliver G. Opitz @eric simon